BioCardia Presents at Alliance for Regenerative Medicine’s (ARM’s) Annual Cell & Gene Therapy Investor Day – PR Newswire (press release)
|
BioCardia Presents at Alliance for Regenerative Medicine's (ARM's) Annual Cell & Gene Therapy Investor Day
PR Newswire (press release) SAN CARLOS, Calif., April 18, 2018 /PRNewswire/ — BioCardia®, Inc., [OTC: BCDA] a leader in cardiovascular regenerative medicine, today announced that it was among the companies providing presentations at the Alliance for Regenerative Medicine's (ARM … |
